Kuangli Bio-Tech Holdings Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	188.04	208.93	41.59	63.22	141.89	162.17
Short-Term Investments	-	-	-	9.19	-	-
Cash & Short-Term Investments	188.04	208.93	41.59	72.41	141.89	162.17
Cash Growth	-43.36%	402.40%	-42.57%	-48.97%	-12.51%	41.71%
Accounts Receivable	77.49	85.26	101.82	73.01	96.86	135.93
Other Receivables	4.65	0.41	2.01	0.28	1.84	85.76
Receivables	82.13	85.66	118.53	135.86	163.32	231.68
Inventory	55.06	53.36	64.24	52.13	63.65	98.87
Prepaid Expenses	-	-	2.69	2.79	9.78	9.55
Other Current Assets	127.87	115.89	22.16	42.52	21.16	20.85
Total Current Assets	453.1	463.84	249.2	305.7	399.79	523.13
Property, Plant & Equipment	417.62	418.88	319.86	380.64	361.44	368.49
Long-Term Investments	3	3	-	-	-	-
Goodwill	101.82	98.89	107.17	128.81	140.42	138.38
Other Intangible Assets	145.04	146.11	166	169.43	189.61	203.62
Long-Term Accounts Receivable	3.68	4.52	7.82	11.07	-	-
Long-Term Deferred Tax Assets	47.15	45.8	45.62	34.69	15.78	1.59
Other Long-Term Assets	19.42	6.3	14.54	12.93	8.52	13.9
Total Assets	1,191	1,187	910.2	1,043	1,116	1,249
Accounts Payable	32.69	49.17	56.53	22.35	29.66	95.15
Accrued Expenses	-	-	-	-	16.87	16.33
Short-Term Debt	205.02	176.11	134.34	147.37	148.42	147.7
Current Portion of Long-Term Debt	-	8.25	30.03	42.08	9.92	-
Current Portion of Leases	32.44	40.38	32.73	32.32	21.27	24.37
Current Income Taxes Payable	-	-	-	-	2.82	4.69
Current Unearned Revenue	59.9	29.99	16.69	10.8	12.7	12.83
Other Current Liabilities	40.43	38.4	37.63	28.18	31.01	27.13
Total Current Liabilities	370.48	342.29	307.95	283.11	272.66	328.19
Long-Term Debt	5.67	6.17	6.25	21.38	12.18	-
Long-Term Leases	255.69	256.43	133.47	178.37	157.97	176.27
Other Long-Term Liabilities	2.01	2.12	2.56	2.49	-	2.18
Total Liabilities	633.84	607.01	450.24	485.34	442.81	506.63
Common Stock	973.99	973.99	723.99	572.39	572.39	511.71
Additional Paid-In Capital	-	274.93	204.33	187.28	187.28	251.72
Retained Earnings	-676.63	-637.91	-444.93	-272.14	-167.98	-243.23
Comprehensive Income & Other	256.19	-33.62	-23.41	-42.91	-32.26	-37.92
Total Common Equity	553.55	577.39	459.97	444.62	559.44	482.27
Minority Interest	3.44	2.94	-	-	-	260.2
Shareholders' Equity	556.98	580.32	459.97	557.92	672.74	742.47
Total Liabilities & Equity	1,191	1,187	910.2	1,043	1,116	1,249
Total Debt	498.81	487.33	336.82	421.52	349.75	348.33
Net Cash (Debt)	-310.77	-278.4	-295.24	-349.11	-207.86	-186.15
Net Cash Per Share	-3.19	-2.99	-4.30	-6.10	-3.69	-3.67
Filing Date Shares Outstanding	96.81	97.4	72.4	57.24	57.24	51.17
Total Common Shares Outstanding	96.81	97.4	72.4	57.24	57.24	51.17
Working Capital	82.63	121.55	-58.75	22.59	127.13	194.94
Book Value Per Share	5.72	5.93	6.35	7.77	9.77	9.42
Tangible Book Value	306.69	332.38	186.8	146.38	229.41	140.28
Tangible Book Value Per Share	3.17	3.41	2.58	2.56	4.01	2.74
Machinery	-	122.35	119.75	116.21	75.91	127.91
Construction In Progress	-	-	-	-	129.26	42.28
Leasehold Improvements	-	145.37	138.89	135.01	24.91	54.63